- Home
- LUD vs ONCY Comparison
LUD vs ONCY Comparison
Compare LUD & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUD
- ONCY
- Stock Information
- Founded
- LUD 2004
- ONCY 1998
- Country
- LUD Hong Kong
- ONCY Canada
- Employees
- LUD N/A
- ONCY N/A
- Industry
- LUD
- ONCY Pharmaceuticals and Biotechnology
- Sector
- LUD
- ONCY Health Care
- Exchange
- LUD NYSE
- ONCY Nasdaq
- Market Cap
- LUD 96.7M
- ONCY 89.7M
- IPO Year
- LUD 2025
- ONCY 1999
- Fundamental
- Price
- LUD $5.63
- ONCY $1.05
- Analyst Decision
- LUD
- ONCY Strong Buy
- Analyst Count
- LUD 0
- ONCY 4
- Target Price
- LUD N/A
- ONCY $4.33
- AVG Volume (30 Days)
- LUD 38.7K
- ONCY 1.5M
- Earning Date
- LUD 01-01-0001
- ONCY 08-08-2025
- Dividend Yield
- LUD N/A
- ONCY N/A
- EPS Growth
- LUD N/A
- ONCY N/A
- EPS
- LUD N/A
- ONCY N/A
- Revenue
- LUD $44,863,430.00
- ONCY N/A
- Revenue This Year
- LUD N/A
- ONCY N/A
- Revenue Next Year
- LUD N/A
- ONCY N/A
- P/E Ratio
- LUD N/A
- ONCY N/A
- Revenue Growth
- LUD N/A
- ONCY N/A
- 52 Week Low
- LUD $3.40
- ONCY $0.33
- 52 Week High
- LUD $9.52
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- LUD N/A
- ONCY 53.00
- Support Level
- LUD N/A
- ONCY $1.18
- Resistance Level
- LUD N/A
- ONCY $1.35
- Average True Range (ATR)
- LUD 0.00
- ONCY 0.13
- MACD
- LUD 0.00
- ONCY -0.03
- Stochastic Oscillator
- LUD 0.00
- ONCY 14.29
About LUD LUDA TECHNOLOGY GROUP LIMITED
Luda Technology Group Ltd is a company that is principally engaged in the manufacture and sale of stainless steel and carbon steel flanges and fittings products and trading of steel pipes, valves, and other steel tubing products.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.